| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.4M | -12.8% | -11.0% |
| R&D Expense | $26.8M | -10.9% | -17.5% |
| SG&A Expense | $8.3M | -5.6% | -16.8% |
| Operating Income | -$31.0M | +29.9% | +12.9% |
| Pre-tax Income | -$41.0M | +26.0% | +6.1% |
| Income Tax | $0 | -100.0% | -100.0% |
| Net Income | -$41.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $234.7M | -11.3% | -14.4% |
| Accounts Receivable | $22.9M | -12.5% | -4.6% |
| Inventory | $18.0M | +1.6% | +12.3% |
| Current Assets | $287.1M | -9.9% | -13.8% |
| Total Assets | $289.8M | -9.9% | -17.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$110.1M | — | — |
| Capital Expenditures | $264K | — | — |
| Investing Cash Flow | -$264K | — | — |
| Financing Cash Flow | $93.9M | — | — |
| Free Cash Flow | -$110.3M | — | — |
| +27.7% |
| +6.8% |
| EPS (Basic) | -$0.30 | +40.0% | +28.6% |
| EPS (Diluted) | -$0.30 | +40.0% | +28.6% |
| $62.0M |
| -4.0% |
| -8.3% |
| Total Liabilities | $527.9M | +1.4% | +1.3% |
| Stockholders' Equity | -$238.2M | -19.6% | -38.5% |